Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-01-13-Speech-2-191"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20090113.22.2-191"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Today we have abstained from the vote on this plant protection legislation.
It is a very difficult vote. We have been involved in all parts of the intense negotiations on this controversial package right up to this point.
The emphasis of this legislation is clearly on health and the links between chemical substances and cancer. Farmers are most affected due to direct contact. While this package seeks to limit the availability of carcinogens, Member States may allow substances on the market where there is a serious threat to plant health. The proposal seeks to protect bees and reduce red tape for substance authorisation. With a gradual withdrawal of substances until 2016, we would urge industry to come up with biologically sound and effective products.
We cannot vote in favour of this legislation. Despite repeated calls for a more recent impact assessment, none was forthcoming from the Commission. We cannot legislate in the abstract! Products will be banned based on hazard as opposed to scientific risk, which would be based on use and exposure. In addition, the definition of “endocrine disruptor” has not been agreed at scientific level and we have tabled amendments to await the opinion of Commission experts to address this."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples